Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for Motor Recovery After Acute Intracerebral Hemorrhage
NCT01737541Phase 3Terminated
- Sponsor
- Universidad Autónoma de Aguascalientes
- Start
- Nov 2012
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Motor Impairment comparing Fluoxetine with Placebo (2 arms). Primary endpoint: Fugl-Meyer Motor Scale at 90 days. Started Nov 2012; status: terminated.
02
Drugs
fluoxetine
03
Conditions
Motor Impairment
Beyond the preview
Go deeper on NCT01737541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01737541.